Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2
This medication is used to protect the bladder wall from the harmful effects of some cancer-fighting drugs
and Ewing's sarcoma and multiple myeloma cell lines are greatest sensitive
2020 Apr 15
Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms
Vadimezan (DMXAA) Size:2mg solid and Selective Inhibitor of Protein-lysineVadimezan, also known as DMXAA and ASA404, is a fused tricyclic analogue of flavone acetic acid with potential antineoplastic activity. Vadimezan induces the cytokines tumor necrosis alpha (TNF alpha), serotonin and nitric oxide, resulting in hemorrhagic necrosis and a decrease in angiogenesis. This agent also stimulates the anti tumor activity of tumor associated macrophages. Product information CAS Number: 117570 53 3 Molecular Weight: 282. 29